Overview

Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts

Status:
Not yet recruiting

Trial end date:
2021-12-01

Target enrollment:
0

Participant gender:
All

Summary

This study compares the safety and efficacy of intralesional Candidal antigen versus Intralesional MMR vaccine versus podophyllin for treatment of genital warts.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Assiut University

Treatments:

Podophyllin
Vaccines

Criteria

Inclusion Criteria:

- Patients with anogenital warts with ages ranging from 3 to 50 years

- Genital warts resistant to treatment

- Genital warts that had relapsed at least once after treatment with any of the
tissue-destructive modalities.

Exclusion Criteria:

- Patients with any evidence of immunosuppression

- Eczematous skin disorder

- Those with any history of hypersensitivity to Candida albicans antigen

- Pregnant or lactating women.